Cargando…

Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study

The aim of this study was to describe the outcomes of targeted COVID-19 treatments in immunocompromised patients with asymptomatic or mild COVID-19 during the period of expansion of the different Omicron subvariants in France. A retrospective monocentric observational study was performed. All immuno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahouati, M., Cazanave, C., Labadie, A., Gohier, P., Guirlé, L., Desclaux, A., Gigan, M., Malvy, D., Pedeboscq, S., Xuereb, F., Duvignaud, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505186/ https://www.ncbi.nlm.nih.gov/pubmed/37717101 http://dx.doi.org/10.1038/s41598-023-42727-5

Ejemplares similares

Consommation d’antibiotiques à l’ère de la COVID-19 : analyse et comparaison entre la 1(re) et 2(e) vague
por: Meunier, C., et al.
Publicado: (2021)

2265. Immunocompromised Patients, Compromised Guidelines? Practice Patterns of Managing Asymptomatic Bacteriuria in Immunocompromised Patients
por: Moore, Jacqueline, et al.
Publicado: (2023)

Aspergillus Tracheobronchitis in a Mild Immunocompromised Host
por: Cho, Byung Ha, et al.
Publicado: (2014)

Dermatoses in international travellers seen at Bordeaux teaching hospital travel clinic, 2015–2018: a GeoSentinel‐based study
por: Blaizot, R., et al.
Publicado: (2020)

Cervical spondylitis and spinal abscess due to Actinomyces meyeri
por: Duvignaud, Alexandre, et al.
Publicado: (2013)

Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept
por: Cèbe, Amélie, et al.
Publicado: (2023)

Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program
por: Camara, Mariame, et al.
Publicado: (2017)

Asymptomatic pulmonary cryptococcosis presenting with mixed lesions of infiltrative and nodular shadow in an immunocompromised patient
por: Ito, Takanori, et al.
Publicado: (2022)

Outcome for immunocompromised pediatric critical patients
por: Peña, Y, et al.
Publicado: (2008)

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
por: Avanzato, Victoria A., et al.
Publicado: (2020)

Post-acute COVID-19 outcomes in children with mild and asymptomatic disease
por: Say, Daniela, et al.
Publicado: (2021)

Short-term perioperative outcomes among patients with concurrent asymptomatic and mild SARS-CoV-2 infection: A retrospective, multicenter study
por: Weitzner, Zachary N., et al.
Publicado: (2022)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

528. Matched Retrospective Study, Comparing Molnupiravir to Nirmatrelvir-Ritonavir (Paxlovid) in the Treatment of Mild-Moderate COVID-19 in Immunocompromised Cancer Patients
por: Haddad, Andrea, et al.
Publicado: (2023)

Delayed organising pneumonia in an immunocompromised host after a mild COVID-19 infection
por: Tiew, Han Wei, et al.
Publicado: (2023)

HPV vaccination of immunocompromised hosts
por: Garland, S.M., et al.
Publicado: (2017)

Asymptomatic Mild Hyperperfusion for the Prediction of Clinical Outcome in Postoperative Patients After Subarachnoid Hemorrhage
por: Nakagawa, Manabu, et al.
Publicado: (2017)

Suivi à 6 mois d’une cohorte de patients immunodéprimés en médecine interne bénéficiant d’une prophylaxie préexposition au SARS-CoV2 par tixagevimab/cilgavimab
por: Liagre, M., et al.
Publicado: (2023)

Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island
por: Duvignaud, A., et al.
Publicado: (2018)

Immunocompromised pediatric patients with acute respiratory failure: outcome and prognosis factors
por: Pujol, M, et al.
Publicado: (2008)

« Coronaaah, c’est quoi ? » : une bande dessinée de vulgarisation scientifique sur le COVID-19
por: Puges, M., et al.
Publicado: (2021)

Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children
por: Chu, Helen Y., et al.
Publicado: (2016)

Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications
por: Spinicci, Michele, et al.
Publicado: (2022)

Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19
por: Kim, G.-u., et al.
Publicado: (2020)

Cytomegalovirus infection of the thyroid in immunocompromised adults.
por: Frank, T. S., et al.
Publicado: (1987)

Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: A retrospective cohort study
por: Wang, Meng, et al.
Publicado: (2021)

Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection
por: Kahn, Rebecca, et al.
Publicado: (2019)

B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review
por: Diks, Annieck M., et al.
Publicado: (2021)

Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
por: Schmidt, Julius J., et al.
Publicado: (2018)

Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients
por: Nasri, Hashem, et al.
Publicado: (2016)

Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study
por: Ferté, Thomas, et al.
Publicado: (2021)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

Infections in the Immunocompromised
por: Cant, Andrew, et al.
Publicado: (2009)

Immunocompromised Patients
por: Humphreys, Hilary, et al.
Publicado: (2012)

Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients
por: Steinbrink, Julie, et al.
Publicado: (2018)

Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021)

Immune memory in convalescent patients with asymptomatic or mild COVID-19
por: Long, Quan-Xin, et al.
Publicado: (2021)

Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form
por: Malkova, Annа, et al.
Publicado: (2021)

Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases
por: Patel, Aditya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rf462gi9afij7d5t7elp9j5nek